跳至主要内容
临床试验/NCT07621172
NCT07621172已完成不适用

Observational Study to Evaluate the Long-term Safety and Efficacy of CartiFill in Subjects With Cartilage Defect of the Knee Joints Who Have Undergone Microfracture Surgery or Microfracture Surgery Using Collagen

Cellontech Co., Ltd.1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2020年2月3日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
1

研究概览

简要总结

The purpose of this clinical trial is to evaluate the safety and efficacy of CartiFill implanted at the site of knee joint cartilage defect in a 6-year, long-term, follow-up investigation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have undergone microfracture surgery or microfracture surgery using collagen 6 years (±1 year) ago as part of the previously conducted post-marketing clinical trial (Protocol No. 03CAR).
  • Males or females aged 19 to 70 years.
  • Patients or patients whose legal representatives have agreed to participate in the clinical trial and signed the written consent.

排除标准

  • Patients who have undergone microfracture surgery or microfracture surgery using collagen as part of previously conducted post-marketing clinical trial (Protocol No. 03CAR) but have since then received cartilage surgery, such as high tibial osteotomy (HTO), partial/full implant arthroplasty, etc., at the same site. (Does not include biopsy for diagnosis, a simple arthroscopic examination, or HTO plate removal procedure, etc.)
  • ※ Does not include non-invasive treatment or medication such as exercise therapy, physical therapy, manual therapy, extracorporeal shock wave, joint cavity injection, etc.
  • Patients who are deemed by the clinical trial manager to be unfit to participate due to psychiatric conditions, etc.

研究者

发起方
Cellontech Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Long-term Safety and Efficacy of CartiFill After... | 临床试验